HealthInvest Partners AB - Q1 2021 holdings

$126 Million is the total value of HealthInvest Partners AB's 15 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 47.1% .

 Value Shares↓ Weighting
IRWD BuyIRONWOOD PHARMACEUTICALS INC$16,211,000
+70.4%
1,450,000
+73.7%
12.91%
+105.0%
SUPN BuySUPERNUS PHARMACEUTICALS INC$13,980,000
+19.5%
534,000
+14.8%
11.13%
+43.7%
ARAY BuyACCURAY INC$9,776,000
+42.1%
1,975,000
+19.7%
7.79%
+70.9%
CHRS BuyCOHERUS BIOSCIENCES INC$9,643,000
-7.5%
660,000
+10.0%
7.68%
+11.2%
BDSI BuyBIODELIVERY SCIENCES INTL IN$7,820,000
+18.2%
2,000,000
+27.0%
6.23%
+42.2%
UTHR NewUNITED THERAPEUTICS CORP DEL$7,694,00046,000
+100.0%
6.13%
VRTX NewVERTEX PHARMACEUTICALS INC$7,521,00035,000
+100.0%
5.99%
ABBV SellABBVIE INC$7,467,000
-19.9%
69,000
-20.7%
5.95%
-3.7%
UHS SellUNIVERSAL HLTH SVCS INCcl b$7,203,000
-23.0%
54,000
-20.6%
5.74%
-7.3%
ABC SellAMERISOURCEBERGEN CORP$6,494,000
-28.6%
55,000
-40.9%
5.17%
-14.1%
MCK SellMCKESSON CORP$6,436,000
-30.2%
33,000
-37.7%
5.13%
-16.0%
CVS NewCVS HEALTH CORP$6,395,00085,000
+100.0%
5.09%
CAH SellCARDINAL HEALTH INC$6,318,000
-30.2%
104,000
-38.5%
5.03%
-16.1%
BMY SellBRISTOL-MYERS SQUIBB CO$6,313,000
-30.3%
100,000
-31.5%
5.03%
-16.2%
CI SellCIGNA CORP NEW$6,285,000
-35.8%
26,000
-44.7%
5.01%
-22.7%
CPRX ExitCATALYST PHARMACEUTICALS INC$0-1,750,000
-100.0%
-3.87%
ATRS ExitANTARES PHARMA INC$0-1,720,000
-100.0%
-4.54%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDsponsored ads$0-915,000
-100.0%
-5.85%
COLL ExitCOLLEGIUM PHARMACEUTICAL INC$0-480,000
-100.0%
-6.37%
VTRS ExitVIATRIS INC$0-525,000
-100.0%
-6.52%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-04-30
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARLES RIV LABS INTL INC17Q4 201712.8%
GILEAD SCIENCES INC16Q4 202214.5%
CARDINAL HEALTH INC15Q4 202214.8%
IMMUCELL CORP15Q2 20171.7%
MCKESSON CORP14Q3 202214.6%
ANTHEM INC12Q4 201714.3%
TRIPLE-S MGMT CORP12Q4 20168.7%
LIFEPOINT HOSPITALS INC11Q2 201613.3%
SUPERNUS PHARMACEUTICALS INC10Q3 202115.5%
ANIKA THERAPEUTICS INC10Q4 201713.0%

View HealthInvest Partners AB's complete holdings history.

Latest significant ownerships (13-D/G)
HealthInvest Partners AB Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVAMED INCMarch 03, 2011405,8755.1%
THERAGENICS CORPFebruary 11, 20093,322,8469.9%
BIO IMAGING TECHNOLOGIES INCJanuary 09, 2009766,4255.3%
ALLION HEALTHCARE INCJuly 07, 2008887,2554.6%
SONIC INNOVATIONS INCJune 26, 20081,328,2014.9%
CANDELA CORP /DE/June 06, 2008697,1643.1%
INTEGRAMED AMERICA INCJune 02, 20082,2000.0%
AFP IMAGING CORPFebruary 04, 200827,5200.2%
OPHTHALMIC IMAGING SYSTEMSDecember 28, 2007834,4404.9%
ANGEION CORP/MNOctober 16, 2007196,0244.8%

View HealthInvest Partners AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-30
13F-HR2023-02-14
13F-HR2022-10-21
13F-HR2022-07-08
13F-HR2022-05-05
13F-HR2022-01-18
13F-HR2021-11-08
13F-HR2021-08-10
13F-HR2021-04-30

View HealthInvest Partners AB's complete filings history.

Compare quarters

Export HealthInvest Partners AB's holdings